KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
2023年10月26日 - 5:05AM
ビジネスワイヤ(英語)
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on the
development, manufacturing, and commercialization of innovative and
easy-to-use subcutaneous infusion solutions that improve quality of
life for patients, today announced that the Company will report
third quarter 2023 financial results on Wednesday, November 8,
2023. KORU Medical’s management will host a conference call and
webcast at 4:30 p.m. ET that day to discuss the financial results
and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (844)-826-3035
for participants in the U.S. or Canada and (412)-317-5195 for
international callers, using conference ID: 10182999. A live and
archived webcast of the event can be accessed via the IR Calendar
on the News/Events page of the Investors section of KORU Medical’s
website at www.korumedical.com. The archived webcast will be
available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous drug delivery systems that
improve quality of life for patients around the world. The FREEDOM
Infusion System currently includes the FREEDOM60® and FreedomEdge®
Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo
Subcutaneous Safety Needle Sets™. These devices are used for
infusions administered in the home and alternate care settings. For
more information, please visit www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231025342856/en/
Investor Contact: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
過去 株価チャート
から 4 2024 まで 5 2024
KORU Medical Systems (NASDAQ:KRMD)
過去 株価チャート
から 5 2023 まで 5 2024